Women's Health News

RSS

Women with epilepsy at risk of infertility

Women with epilepsy may be more likely to experience infertility, according to new research published in the October 12, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

12 Oct 2010

HHS awards $5 million grant to support teen pregnancy prevention programs

The George Washington University School of Public Health and Health Services (SPHHS), in partnership with three community-based organizations, has been awarded a five-year, $5 million grant from the Department of Heath and Human Service's (HHS) Office of Adolescent Health. This grant is part of a $155 million commitment by HHS to support the replication of teen pregnancy prevention programs that have been shown to be effective through rigorous research as well as the testing of new, innovative approaches to combating teen pregnancy.

12 Oct 2010

Estrogen therapy increases risk of kidney stone development in postmenopausal women

Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Oct 2010

$750 million needed to treat obstetric fistula until 2015

A report released by the United Nations today calls for intensified investment in cost-effective interventions to address the problem of obstetric fistula. The document estimates that at least $750 million is needed to treat existing and new cases between now and 2015. Caused by prolonged, obstructed labour without timely medical intervention, the condition affects as many as 3.5 million women in the world.

11 Oct 2010

Identifying subsets of patients who will respond to subsequent lines of chemotherapy

In a study presented at the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Giovanni Bernardo from Fondazione Maugeri in Pavia, Italy, presented results that suggested it may be possible to identify subsets of metastatic breast cancer patients who are likely to respond to subsequent lines of chemotherapy.

11 Oct 2010

Fertility concerns of cancer survivors inadequately addressed, study finds

Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.

11 Oct 2010

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment. At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Tim Perren from Leeds Teaching Hospitals NHS Trust, UK, reported findings from the international ICON7 trial, which included 1528 women with high-risk early or advanced stage epithelial ovarian cancer, primary peritoneal cancer or Fallopian tube cancer.

11 Oct 2010

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.

11 Oct 2010

Baby born from 20 year old frozen embryo

A 42 year old mother gave birth to a baby born from an embryo frozen 20 years ago. This is the longest time a fertilized egg has been stored before developing into a healthy baby, and could eventually lead to thousands of women having children in middle age feel experts.

11 Oct 2010

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Atomic Tattoos has announced the launch of their "Tats for Tatas" fundraising campaign that will take place throughout October, benefiting the Florida Breast Cancer Foundation in Florida and Southeast Regional Breast Cancer Fund in Wisconsin. In the company's concerted efforts to raise awareness and funds for Breast Cancer Awareness, Atomic Tattoos is offering several specials throughout the month if customers donate $5 to breast cancer awareness.

11 Oct 2010

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.

11 Oct 2010

Upward trend for post-breast feeding breast augmentation procedures

The Harley Medical Group, Ireland's leading cosmetic surgery provider, has revealed breast surgery is top of the ops for the 23rd year running and the fastest growing sector of cosmetic surgery. The Harley Medical Group has seen a positive increase on last year's enquiries. While breast reductions are becoming more popular with an increasing number of Irish women reducing their breast size in order to achieve a more slender figure, breast augmentation continues to be the most popular procedure performed at THMG's Dublin clinic.

11 Oct 2010

Persimmon Scientific to showcase antimicrobial nursing pads, hypoallergenic diaper liners at 8th ABC Kids Expo

Persimmon Scientific, Inc., dedicated to integrating technical and engineered fabrics into innovative, patentable medical products that promote skin comfort and improve quality of life, will be exhibiting at the First Timers Pavilion Booth #4439 and New Products Showcase at the upcoming ABC Kids Expo, the primary trade show for the juvenile products industry.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

Tips to keep bones strong

October 20 is World Osteoporosis Day. Most people know that osteoporosis is a condition that affects many older women. Though osteoporosis isn't as common in men -- because most men have naturally larger and stronger bones -- they can get it, too.

11 Oct 2010

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.

11 Oct 2010

The Atlantic reports on potential challenges to passage of the International Violence Against Women Act

The Atlantic looks at the challenges facing the passage of I-VAWA (S.2982, HR. 4594), or the International Violence Against Women Act, which was recently delayed in Congress.

11 Oct 2010

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Leading national researchers in the fight against breast cancer will convene Oct. 26-29 for the 2010 Advances in Breast Cancer Research Workshop at the University of Arkansas. More than 70 scientists from diverse research areas in science, medicine, engineering and technology will participate. Ten featured speakers will present cutting-edge research on breast cancer diagnosis, therapeutic techniques, treatment and screening.

11 Oct 2010

Novel hormonal treatments may help ER-negative breast cancer patients: Study

Women who have estrogen (ER) negative breast cancer may have more drug treatment options than previously thought, a Creighton (pronounced Cray-ton) University study suggests. The study is reported in the Oct. 11 online version of the journal Oncogene.

11 Oct 2010

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

PlastiPure, a safer-plastics technology company, has announced a partnership with ReliaBrand to license infant feeding, sports bottle, food packaging, and medical products free of harmful chemicals that cause estrogenic activity (EA). Chemicals with EA have been strongly linked to adverse health effects such as birth defects, reproductive cancers, and behavioral and learning disorders. The widely known chemicals BPA and phthalates are only a few of thousands of chemicals suspected to have EA.

11 Oct 2010

Women's Health News

Women with epilepsy at risk of infertility

HHS awards $5 million grant to support teen pregnancy prevention programs

Estrogen therapy increases risk of kidney stone development in postmenopausal women

$750 million needed to treat obstetric fistula until 2015

Identifying subsets of patients who will respond to subsequent lines of chemotherapy

Fertility concerns of cancer survivors inadequately addressed, study finds

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

Baby born from 20 year old frozen embryo

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

Upward trend for post-breast feeding breast augmentation procedures

Persimmon Scientific to showcase antimicrobial nursing pads, hypoallergenic diaper liners at 8th ABC Kids Expo

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Tips to keep bones strong

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

The Atlantic reports on potential challenges to passage of the International Violence Against Women Act

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Novel hormonal treatments may help ER-negative breast cancer patients: Study

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News